Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer

Angiogenesis pathway genes show substantial genetic variability causing inter-individual differences in responses to anti-angiogenic drugs. We examined 20 single nucleotide polymorphisms (SNPs) in 13 of these genes to predict tumour response and clinical outcome measured as progression free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaibar, María, Galán, Miguel, Romero-Lorca, Alicia, Antón, Beatriz, Malón, Diego, Moreno, Amalia, Fernández-Santander, Ana, Novillo, Apolonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866547/
https://www.ncbi.nlm.nih.gov/pubmed/33573134
http://dx.doi.org/10.3390/ijms22031381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866547/
https://www.ncbi.nlm.nih.gov/pubmed/33573134
http://dx.doi.org/10.3390/ijms22031381

Ejemplares similares